Skip to site navigation.
Skip to section navigation.
Skip to main page content.
Search
Follow us on Facebook Follow us on Twitter Follow us on YouTube Share this page

Cancer Pharmacology


Degrees Available



MSc Full-time

Suitable for International Students?

Yes

Award Tuition Fees Attendance Mode Length of Course
MSc

2012/13

  • Home /EU: £4,900
  • International: £13,250

(A small increase can be expected for the subsequent year)

Full-time 12 months
September

Course Introduction

Based upon a greater understanding of the molecular aspects of cancer, new opportunities for therapeutic intervention have emerged that are effectively 'target orientated'. These new therapeutics are quite distinct from the classical chemotherapeutic agents and they offer the prospect of truly selective cancer therapies that are tailored towards the individual patient's tumour. This is an exciting time to be involved in cancer therapeutics and cancer pharmacology plays a key role in drug development. In both the laboratory and the clinic, cancer pharmacology has had to adapt to the changing face of drug development by establishing experimental models and target orientated approaches.

The programme is designed to provide you with a 'state-of-the-art' course in modern cancer pharmacology that meets the demand of employers and an expert view of the available cancer medicines and the development of new cancer therapies.

It promotes advanced scholarship within specialised areas at the same time as the development of key transferable skills (in IT and bioinformatics) and research techniques.

Course Syllabus

2011/12: All Modules are Core

Semester 1 (60 Credits - 4 Modules):

  • Critical Appraisal of a Current Topic in Cancer Biology (20 Credits split across both Semesters, 10 Credits per Semester)
  • Molecular Basis of Cancer and Cancer Therapy (20 Credits)
  • Preclinical Models for Drug Evaluation (20 Credits)
  • Research and Analytical Methods (20 Credits split across both Semesters, 10 Credits per Semester)

Semester 2 (60 Credits - 4 Modules):

  • Cancer Pharmacology (20 Credits)
  • Critical Appraisal of a Current Topic in in Cancer Biology (20 Credits split across both Semesters, 10 Credits per Semester)
  • Experimental Design (20 Credits)
  • Research and Analytical Methods (20 Credits split across both Semesters, 10 Credits per Semester)

End of Semester 2 onwards (60 Credits - 1 Module);

  • Research Project in Cancer Pharmacology (60 Credits)

Special Features

  • The course is hosted by the Institute of Cancer Therapeutics which has a strong research ethos and it is particularly well known as a centre of excellence in Cancer Pharmacology
  • It benefits from the multidisciplinary team of researchers in the field of anti-cancer drug design, synthesis, screening and pharmacology both at the University and through our extensive links with experts at other universities and industry
  • You will also benefit from working in excellent research laboratories in a research-focused environment

Entry Requirements

  • 2:2 or above in a science subject
  • Applications are welcome from candidates with non-standard qualifications, who have significant relevant experience

Level of English Required

IELTS at 6.0 or the equivalent.

[Full information on our General English Language Requirements]

Student Quotes

Visit the Institute of Cancer Therapeutics website for student quotes and video testimonials at www.cancer.brad.ac.uk/postgraduate-study.

Contact Details

School of Life Sciences Postgraduate Admissions Administrator (Master's courses)

Download Prospectus

Life Sciences School Prospectus 2012 (PDF 5MB)

Please note that these PDFs are correct as at time of print (November 2011). For the most up to date course information please use the web page.

Cognate Course

Yes